The benchmark for what a laboratory information management system (LIMS) should deliver is shifting, driven by rising data complexity, tightening regulatory requirements, and demand for faster decisions. LabVantage Solutions received Visionary Leader recognition in both the Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026 and the Frost Radar™: Laboratory Information Management Systems in Industrial Applications, 2026, marking its fourth consecutive year of Frost Radar leadership. The dual recognition centers on LabVantage CORTEX, the company's agentic AI framework, which Frost & Sullivan identified as the first of its kind among enterprise LIMS vendors.
Why Did LabVantage Win Both LIMS Frost Radar Categories In 2026?
Frost & Sullivan credited LabVantage's Visionary Leader placement to three factors: LabVantage CORTEX, its integrated platform spanning LIMS, electronic laboratory notebook (ELN), laboratory execution system (LES), scientific data management system (SDMS), and advanced analytics, and a broad cross-industry footprint.
The Frost Radar™ methodology benchmarks vendors on two axes. A Growth Index measures growth performance, track record, and ability to execute a growth strategy, while an Innovation Index evaluates the ability to develop globally applicable solutions that evolve with changing customer needs. For the 2026 assessments, Frost & Sullivan benchmarked 16 companies in life sciences and screened 50 vendors in industrial applications, plotting the top 10 in that category.
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
For life sciences, the evaluation highlighted LabVantage's configurable, browser-based platform, which integrates its LIMS alongside ELN, LES, SDMS, and advanced analytics in a single architecture. CORTEX was built as a separate layer from the core LIMS, so AI capabilities can advance without touching validated workflows. The industrial report credited LabVantage's cross-sector footprint and double-digit market growth.
The FDA's February 2026 software assurance guidance formalizes a risk-based approach that scales validation effort to each software's intended use, directly supporting the modular AI deployment LabVantage has pursued with CORTEX. For regulated laboratories, this marks a practical shift away from blanket documentation requirements and toward proportionate assurance.
Anantharaman Viswanathan, Research Director at Frost & Sullivan, explains: "LabVantage is the first enterprise LIMS vendor to offer a comprehensive agentic AI framework... By building LabVantage CORTEX separately from the validated LIMS core, the company allows AI capabilities to evolve quickly without disrupting regulated operations. "
Frost & Sullivan's 2026 assessments credited LabVantage across five dimensions:
- Agentic AI framework (LabVantage CORTEX) layered above the validated LIMS platform to keep AI and regulated workflows separate
- Integrated platform spanning LIMS, ELN, LES, SDMS, and advanced analytics in a single browser-based architecture
- Customer retention above 98% and growing Software as a Service (SaaS) adoption in the life sciences segment
- Cross-industry industrial footprint spanning food and beverage, oil and gas, consumer goods, forensics, and government laboratories
- Human-in-the-loop model in which robotics, automation, and agentic AI support the scaling of routine workflows while scientists retain interpretation and critical decisions
Where LabVantage LIMS Is Deployed Across Industries
LabVantage's LIMS covers both regulated life sciences workflows and an industrial base spanning food, beverage, energy, forensics, and government sectors. Frost & Sullivan identified this cross-sector scale as a primary driver of LabVantage's growth in the LIMS market.
In industrial settings, the evaluation recognized deployments across food and beverage quality testing, oil and gas monitoring, consumer goods manufacturing, forensics, and government laboratory operations. Within life sciences, CORTEX agents in development target worksheet generation, sample management, and stability protocol construction, all within auditable guardrails. The report also noted LabVantage's preference for augmentation over full automation.
The 2026 assessments produced the following headline results:
| Recognition Area | Summary |
|---|---|
| Life Sciences Frost Radar | Visionary Leader; 16 companies benchmarked |
| Industrial Applications Frost Radar | Visionary Leader; 50 vendors screened, top 10 plotted |
| Consecutive Years Of Leadership | Fourth consecutive Frost Radar recognition |
| Customer Retention (Life Sciences) | Above 98% |
| Market Growth | Strong double-digit growth cited in both reports |
| AI Architecture | CORTEX layered separately above the validated LIMS platform |
LabVantage announced the recognition at its Customer Training and Education Conference (CTEC) Europe 2026 in Paris. Mikael Hagstroem, CEO of LabVantage Solutions, remarks: "Offering a trusted agentic AI environment for high-stakes, regulated industries is a proud milestone, and I am incredibly grateful to my colleagues for launching LabVantage CORTEX. Built in collaboration with leading global laboratories, CORTEX delivers relevant and impactful agentic AI that gives scientists trusted auditable automation without compromising compliance or data integrity."
LabVantage CORTEX Reframes What Regulated LIMS Can Deliver
Independent dual recognition across life sciences and industrial LIMS categories positions LabVantage as a vendor that has expanded what a laboratory information management system can do without loosening compliance requirements. CORTEX's separation from the core LIMS is the key architectural decision; whether agentic AI can perform at scale in regulated, auditable workflows is a question the broader laboratory sector will be watching. The Frost & Sullivan summary reports are available on the LabVantage website.
This article is based on a press release by LabVantage and was produced under Separation Science's AI Editorial Guidelines.
